β-cell Functional Test | BChealth —
Percise Treatment with Precise Diagnosis
If your heart is not feeling well, you will check your heart;
If you have a persistent cough, you will check your lungs;
If your blood glucose is elevated, what should you check?
The pancreas is an important organ for controlling blood glucose. Have you checked it?
Identifying Diabetes Type with Precision
BChealth is a comprehensive diabetes classification test that measures fasting blood glucose and C-peptide to calculate insulin resistance and islet β-cell function index (HOMA), and islet cell autoantibody levels. The test helps doctors identify a patient's diabetes type accurately in order to formulate the best treatment plan possible, including insulin therapy, oral medication, weight control, etc.
.png)
C-peptide
Reflects the amount of insulin secreted in the body
.png)
Islet cell autoantibodies
Destroy β-cells in the body
(related to type 1 diabetes and LADA)
Insulin resistance index
Reflects the body’s sensitivity to insulin
.png)
β-cell functional index
Reflects the functionality of β-cells in the body
If you suffer from diabetes, want to know your diabetes type, and whether your current treatment is appropriate and effective, BChealth is your best choice.
Did you know?
Two Major Conditions Caused by Diabetes
Knowing the type of your diabetes, your doctor can develop a more precise treatment direction for you, especially since many people may simultaneously suffer from:
.png)
The body fails to produce enough insulin to control blood glucose levels due to a lack of pancreatic beta cells or abnormal beta cell function. The main treatment method is insulin therapy.
The sensitivity of the body's cells to insulin is reduced due to factors such as obesity, which prevents blood glucose from entering cells, thus leaving blood glucose levels uncontrolled. The main treatment methods are oral medications and weight control. Patients suffering from severe or long-term diabetes may also need insulin.
Supported by Two Authoritative Diabetes Organizations
Different types of diabetes present similar clinical characteristics even though the appropraite treatments can be very different. Currently, doctors mostly identify the diabetes type of a patient by using a step-by-step elimination method before deciding on a treatment course. Unfortunately, this method is both inefficient and time-consuming. Often, patients are classified incorrectly, thereby missing out on the most appropriate treatments. According to a report jointly published by the American Diabetes Association and the European Association for the Study of Diabetes – two authoritative diabetes organizations – patients should be tested for C-peptide and islet cell antibodies to classify diabetes¹, in order to enable doctors to seize the golden period to formulate the most appropriate treatment plan for each patient.
Target Groups
People with the following conditions
People who are about to change their treatment (For example insulin/SGLT2i/De-escalated treatment)
People who clinical features do not suggest a definitive classification
People suspected of having type 1 diabetes
Complete Your Journey with GemVCare
How it works
Specimens will be sent to our testing center for analysis and the test will be completed within 14 working days.
02
01
Collect specimens at designated centers
•Blood specimen
03
Reports will be explained by your healthcare provider and an appropriate disease management plan will be designed accordingly.
Users's Experience
"BChealth is the most detailed test for assessing pancreatic islet function!"
Tracy
I have been suffering from diabetes for many years and have always taken my medicine on time. Because I have a higher risk of cardiovascular disease, my doctor recently recommended me to use the latest drugs - SGLT2 inhibitors. However, he is worried that I have insufficient insulin in my body due to years of diabetes, as using new drugs may increase the risk of ketoacidosis.
Before switching to a new medication, he suggested that I take a BChealth test to evaluate my insulin secretion and pancreatic beta cell function. The test results showed that I had enough insulin in my body, but my pancreatic beta cells were functioning poorly. The doctor said that at my current stage, I could take the new medicine with peace of mind, as long as I undergo regular BChealth tests to monitor my pancreatic function. After taking the new medication, my condition became more stable and I felt truely reassured.
BChealth was very helpful in assessing my diabetes. The doctor was able to improve my treatment in line with my personal situation, and I no longer worry about the serious side effects that may be triggered when changing medications.
*This story is inspired by our users' experiences and feedbacks and is presented here as illustration. Since each patient is unique, our services should not be seen in any way as guaranteeing outcomes.
References：
-
Holt, Richard I. G., et al. “The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).” Diabetologia, vol. 64, no. 12, 2021, pp. 2609–2652., https://doi.org/10.1007/s00125-021-05568-3.